Skip to main content

Table 2 Clinicopathological Characteristics between patients grouped by NLR or PLR

From: The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy

Characteristics

NLR

PLR

NLR < 2.47 (Number, %)

NLR ≥ 2.47 (Number, %)

p

PLR < 136 (Number, %)

PLR ≥ 136 (Number, %)

p

Total Gender

191(100)

147(100)

 

172(100)

166(100)

 

 Male

109(57.1)

118(80.3)

0.000

117(68)

110(66.3)

0.731

 Female

82(42.9)

29(19.7)

 

55(32)

56(33.7)

 

Age (year)

  < 65

155(81.2)

114(77.6)

0.416

141(82)

128(77.1)

0.267

  ≥ 65

36(18.8)

33(22.4)

 

31(18)

38(22.9)

 

Smoking

 Yes

92(48.2)

82(55.8)

0.165

99(57.6)

75(45.2)

0.023

 No

99(51.8)

65(44.2)

 

73(42.4)

91(54.8)

 

Alcohol

 Yes

73(38.2)

70(47.6)

0.083

71(41.3)

72(43.4)

0.697

 No

118(61.8)

77(52.4)

 

101(58.7)

94(56.6)

 

TNM Stage

 Stage I-II

64(33.5%)

33(22.4%)

0.026

51(29.7%)

46(27.7%)

0.693

 Stage III-IV

127(66.5%)

114(77.6%)

 

121(70.3%)

120(72.3%)

 

Tumor length

  < 5 cm

68(35.6%)

30(20.4%)

0.002

60(34.9%)

38(22.9%)

0.015

  ≥ 5 cm

123(64.4%)

117(79.4%)

 

112(65.1%)

128(77.1%)

 

Tumor location

 Upper thoracic

62(32.5%)

33(22.4%)

0.061

56(32.6%)

39(23.5%)

0.160

 Middle thoracic

93(48.7%)

74(50.3%)

 

78(45.3%)

89(53.6%)

 

 Lower thoracic

36(18.8%)

40(27.3%)

 

38(22.1%)

38(22.9%)

Â